the 2016 Annual General Shareholders’ Meeting of Epigenomics AG has taken place on May 25, 2016.
Documents for the upcoming 2017 Annual General Shareholders’ Meeting (preliminary date: May 30, 2017) will be made available on this website.
Documents below were published for the past 2016 Annual General Shareholders’ Meeting.
|Invitation to the Annual General Shareholders’ Meeting 2016 of Epigenomics AG|
|Report of the Executive Board on agenda items 6, 7, 8 and 9|
|Annual Report 2015
(incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report)
|Financial Statements 2015
(German HGB) incl. Key features of the internal control and risk management system (German version)
|Explanatory Report by the Management Board on Disclosures Pursuant to Section 289 (4), Section 315 (4) HGB (German version)|
|Explanatory Report by the Management Board on Key Features of the Internal Control and Risk Management System Related to the Group Accounting Procedures of the Company Pursuant to Section 289 (5), Section 315 (2) HGB (German version)|
|Counterproposal as of May 09, 2016|
Corporate Governance/Declaration of Governance
|Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG)|
|Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB)|
|Explanation of Shareholders’ rights|
|Articles of Association|
|Form for the transfer of voting rights
|Item 5 of the agenda: Introduction of Dr. Helge Lubenow for Election of member of the Supervisory Board|